Increased SNX20 and PD-L1 Levels Can Predict the Clinical Response to PD-1 Inhibitors in Lung Adenocarcinoma. - Fan, Linwei; Li, Li; Huang, Chunye; Huang, Shanshan; Deng, Jun; Xiong, Jianping (OncoTargets & Therapy, 2020)